# Study of Midazolam in Healthy Adults

> **NCT04679623** · PHASE1 · COMPLETED · sponsor: **Rafa Laboratories** · enrollment: 40 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **COMBINATION_PRODUCT:** Midazolam
- **DRUG:** Seizalam

## Key facts

- **NCT ID:** NCT04679623
- **Lead sponsor:** Rafa Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-09
- **Primary completion:** 2021-09-17
- **Final completion:** 2021-09-17
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04679623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04679623, "Study of Midazolam in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04679623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*